This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2020 Oct 15;5(20):e144624.

doi: 10.1172/jci.insight.144624.

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis

PMID: 33055421
PMCID: PMC7605530
DOI: 10.1172/jci.insight.144624

Published Erratum

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis

Michael P Pender et al. JCI Insight. 2020.

. 2020 Oct 15;5(20):e144624.

doi: 10.1172/jci.insight.144624.

PMID: 33055421
PMCID: PMC7605530
DOI: 10.1172/jci.insight.144624

No abstract available

PubMed Disclaimer

Figures

Figure 3

See this image and copyright information in PMC

Erratum for

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R. Pender MP, et al. JCI Insight. 2018 Nov 15;3(22):e124714. doi: 10.1172/jci.insight.124714. JCI Insight. 2018. PMID: 30429369 Free PMC article. Clinical Trial.

Similar articles

Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.
Holmøy T, Kvale EØ, Vartdal F. Holmøy T, et al. J Neurovirol. 2004 Oct;10(5):278-83. doi: 10.1080/13550280490499524. J Neurovirol. 2004. PMID: 15385250
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells.
Holmøy T, Vartdal F. Holmøy T, et al. J Neurovirol. 2004 Feb;10(1):52-6. doi: 10.1080/13550280490261671. J Neurovirol. 2004. PMID: 14982728
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Jons D, Sundström P, Andersen O. Jons D, et al. Acta Neurol Scand. 2015 Feb;131(2):69-79. doi: 10.1111/ane.12294. Epub 2014 Sep 11. Acta Neurol Scand. 2015. PMID: 25208981 Review.
The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus.
Haahr S, Munch M. Haahr S, et al. J Neurovirol. 2000 May;6 Suppl 2:S76-9. J Neurovirol. 2000. PMID: 10871790 Review.
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F. Serafini B, et al. J Virol. 2019 Nov 26;93(24):e00980-19. doi: 10.1128/JVI.00980-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578295 Free PMC article.

See all similar articles

Cited by

The role of the complement system in Multiple Sclerosis: A review.
Saez-Calveras N, Stuve O. Saez-Calveras N, et al. Front Immunol. 2022 Aug 10;13:970486. doi: 10.3389/fimmu.2022.970486. eCollection 2022. Front Immunol. 2022. PMID: 36032156 Free PMC article. Review.
Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials.
Lanz TV, Robinson WH, Ho PP, Steinman L. Lanz TV, et al. Clin Transl Immunology. 2023 Feb 16;12(2):e1438. doi: 10.1002/cti2.1438. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36815946 Free PMC article. Review.
Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
Bjornevik K, Münz C, Cohen JI, Ascherio A. Bjornevik K, et al. Nat Rev Neurol. 2023 Mar;19(3):160-171. doi: 10.1038/s41582-023-00775-5. Epub 2023 Feb 9. Nat Rev Neurol. 2023. PMID: 36759741 Review.
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System.
Andersen O, Ernberg I, Hedström AK. Andersen O, et al. Infect Drug Resist. 2023 Jul 13;16:4599-4620. doi: 10.2147/IDR.S375624. eCollection 2023. Infect Drug Resist. 2023. PMID: 37465179 Free PMC article. Review.
Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis.
Piehl F. Piehl F. J Intern Med. 2021 Jun;289(6):771-791. doi: 10.1111/joim.13215. Epub 2020 Dec 20. J Intern Med. 2021. PMID: 33258193 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database